课题基金 / 基金详情

Gene Expression and Diagnosis of Autoimmune Disease

Gene Expression and Diagnosis of Autoimmune Disease
自身免疫性疾病的基因表达和诊断
批准号:
6838105
负责人:
Thomas M. Aune
金额:
$36.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-02-15 至 2006-06-30

项目摘要

项目成果

Thomas M. Aune的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Autoimmune diseases are thought to arise from abnormalities in innate or adaptive immune responses and most likely have both genetic and environmental components. Diagnosis of autoimmune disease is often difficult, as the symptoms can be relatively nonspecific. Furthermore, no available blood test can accurately exclude the possibility of an autoimmune disease in a subject with such symptoms. At best, a battery of tests and a period of observation are usually required to establish that a patient does in fact have an autoimmune disorder. Using microarray technology, we have found that individuals with any of four distinct autoimmune diseases have a common gene expression signature that is independent of the specific clinical entity, but which is totally distinct from the normal immune response. Based upon these observations, we have developed a simple test for excluding the possibility that a subject has an autoimmune disorder. In Phase I we have shown that this test is present in early disease and has distinct differences from non-autoimmune disorders. We have confirmed the identities of the genes in our arrays and developed an approach for production of diagnostic arrays. This Phase II proposal is to continue this work has three specific aims. The first is to optimize the gene array platform. The second is to test the diagnostic tool in patients with early, undifferentiated disease and with other diseases to confirm specificity. The third is to compare the results to those obtained with existing tests. The result of this phase will be a test that is feasible for applications in research and clinical care
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alu dsRNAs as adjuvants for influenza vaccines
Alu dsRNAs as adjuvants for influenza vaccines
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses
海外基金